Recombinant Human Platelet–Derived Growth Factor: A Systematic Review of Clinical Findings in Oral Regenerative Procedures

AIM: The use of recombinant human platelet-derived growth factor–BB (rhPDGF) has received Food and Drug Administration approval for the treatment of periodontal and orthopedic bone defects and dermal wound healing. Many studies have investigated its regenerative potential in a variety of other oral...

Descripción completa

Detalles Bibliográficos
Autores principales: Tavelli, L., Ravidà, A., Barootchi, S., Chambrone, L., Giannobile, W.V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961612/
https://www.ncbi.nlm.nih.gov/pubmed/32392438
http://dx.doi.org/10.1177/2380084420921353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961612/
https://www.ncbi.nlm.nih.gov/pubmed/32392438
http://dx.doi.org/10.1177/2380084420921353

Ejemplares similares